Clinical trialNCT00614939CompletedPhase 3Interventional

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

SponsorAstraZenecaEnrollment572Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Deborah Price, MSc
AstraZeneca
Study Chair
clinicaltrials.gov ↗
Peter Ohman, MD, PhD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belarus

Research Site
Brest, Belarus
Research Site
Homyel, Belarus
Research Site
Minsk, Belarus

Bulgaria

Research Site
Dimitrovgrad, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Veliko Tarnovo, Bulgaria

Croatia

Research Site
Rijeka, Croatia, Croatia
Research Site
Karlovac, Croatia
Research Site
Osijek, Croatia
Research Site
Split, Croatia
Research Site
Zagreb, Croatia

Czechia

Research Site
Moravský Krumlov, Czechia
Research Site
Prague, Czechia
Research Site
Teplice, Czechia
Research Site
Znojmo, Czechia
Research Site
Ústí nad Labem, Czechia

Estonia

Research Site
Tallinn, Estonia

Germany

Research Site
Dieburg, Germany
Research Site
Düsseldorf, Germany
Research Site
Hanover, Germany
Research Site
Heidelberg, Germany
Research Site
Mannheim, Germany

Hungary

Research Site
Debrecen, Hungary
Research Site
Győr, Hungary
Research Site
Kalocsa, Hungary
Research Site
Kecskemét, Hungary
Research Site
Zalaegerszeg, Hungary

Latvia

Research Site
Riga, Latvia

Lithuania

Research Site
Kaunas, Lithuania
Research Site
Klaipėda, Lithuania
Research Site
Panevezys, Lithuania
Research Site
Vilnius, Lithuania

Poland

Research Site
Lodz, 90-153, Poland
Research Site
Bialystok, Poland
Research Site
Ciechanów, Poland
Research Site
Golub-Dobrzyń, Poland
Research Site
Grodzisk Mazowiecki, Poland
Research Site
Katowice, Poland
Research Site
Krakow, Poland
Research Site
Maków Mazowiecki, Poland

34 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2008
Primary completion: 30 Jun 2009
Completion: 31 Mar 2010
Last update posted: 19 May 2011
Registered enrollment: 572
Registry id: NCT00614939

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.